Business Description
NeuroOne Medical Technologies Corp
NAICS : 339113
SIC : 5047
ISIN : US64130M1009
Description
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.59 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -21.13 | |||||
| Beneish M-Score | -1.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16.7 | |||||
| 3-Year EPS without NRI Growth Rate | 34.3 | |||||
| 3-Year FCF Growth Rate | -3.8 | |||||
| 3-Year Book Growth Rate | -2.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.27 | |||||
| 9-Day RSI | 32.49 | |||||
| 14-Day RSI | 33.9 | |||||
| 6-1 Month Momentum % | -11.26 | |||||
| 12-1 Month Momentum % | -29.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.42 | |||||
| Quick Ratio | 1.36 | |||||
| Cash Ratio | 0.96 | |||||
| Days Inventory | 208.15 | |||||
| Days Sales Outstanding | 46.83 | |||||
| Days Payable | 103.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -47.9 | |||||
| Shareholder Yield % | -57.26 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.86 | |||||
| Operating Margin % | -311.88 | |||||
| Net Margin % | -308.51 | |||||
| FCF Margin % | -290.29 | |||||
| ROE % | -282.07 | |||||
| ROA % | -201.82 | |||||
| ROIC % | -840.66 | |||||
| ROC (Joel Greenblatt) % | -891.89 | |||||
| ROCE % | -280.23 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.95 | |||||
| PB Ratio | 5.74 | |||||
| Price-to-Tangible-Book | 5.64 | |||||
| EV-to-EBIT | -1.45 | |||||
| EV-to-EBITDA | -1.48 | |||||
| EV-to-Revenue | 4.53 | |||||
| EV-to-Forward-Revenue | 3.94 | |||||
| EV-to-FCF | -1.56 | |||||
| Price-to-Net-Current-Asset-Value | 7.75 | |||||
| Earnings Yield (Greenblatt) % | -68.97 | |||||
| FCF Yield % | -59.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NMTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NeuroOne Medical Technologies Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3.923 | ||
| EPS (TTM) ($) | -0.48 | ||
| Beta | 1.17 | ||
| Volatility % | 76.79 | ||
| 14-Day RSI | 33.9 | ||
| 14-Day ATR ($) | 0.082299 | ||
| 20-Day SMA ($) | 0.80155 | ||
| 12-1 Month Momentum % | -29.54 | ||
| 52-Week Range ($) | 0.5771 - 2 | ||
| Shares Outstanding (Mil) | 30.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NeuroOne Medical Technologies Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NeuroOne Medical Technologies Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
NeuroOne Medical Technologies Corp Frequently Asked Questions
What is NeuroOne Medical Technologies Corp(NMTC)'s stock price today?
The current price of NMTC is $0.62. The 52 week high of NMTC is $2.00 and 52 week low is $0.58.
When is next earnings date of NeuroOne Medical Technologies Corp(NMTC)?
The next earnings date of NeuroOne Medical Technologies Corp(NMTC) is 2024-12-13 Est..
Does NeuroOne Medical Technologies Corp(NMTC) pay dividends? If so, how much?
NeuroOne Medical Technologies Corp(NMTC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers